Insider Trading May 21, 2026 05:37 PM

D-Wave Executive Sells Shares; Company Reports Mixed Financial Signals Amid Quantum Funding Boost

Analysis of Sophie Ames's recent stock transaction and D-Wave Quantum's Q1 2026 earnings report, alongside major funding announcements.

By Derek Hwang QBTS

Sophie C. Ames, EVP and CHRO at D-Wave Quantum Inc., executed a sale of company common stock totaling $436,933 on May 20, 2026. The transaction occurred under an established Rule 10b5-1 trading plan. Separately, the company reported its Q1 2026 earnings, which showed an EPS of -$0.05, surpassing analyst expectations of -$0.08, though revenue fell short of $4.14 million. D-Wave also secured a Letter of Intent for $100 million in proposed funding via the U.S. CHIPS and Science Act.

D-Wave Executive Sells Shares; Company Reports Mixed Financial Signals Amid Quantum Funding Boost
QBTS

Key Points

  • The recent $100 million Letter of Intent funding through the U.S. CHIPS and Science Act indicates significant external support for D-Wave's quantum computing development.
  • While Q1 2026 earnings showed an EPS of -$0.05, surpassing analyst expectations of -$0.08, the company's revenue of $2.9 million fell below the anticipated $4.14 million mark.
  • The sale of shares by Executive Vice President Sophie Ames occurred under a pre-planned Rule 10b5-1 trading strategy, which is common for managing insider liquidity.

Sophie C. Ames, Executive Vice President and Chief Human Resources Officer at D-Wave Quantum Inc., recently completed a transaction involving the sale of company common stock. On May 20, 2026, Ms. Ames sold shares totaling $436,933.

The details of this divestiture indicate that 23,025 shares were disposed of. The selling prices ranged from a low of $18.35 up to $19.40 per share. Based on these specific sale prices, the weighted average transaction price for the shares was determined to be $18.9765.

It is important to note that since this sale, D-Wave Quantum's stock has seen an increase, climbing to $25.72. This movement highlights the variable and dynamic nature of share valuation within the quantum computing sector.

The execution of this transaction was not discretionary but rather automated, following a Rule 10b5-1 trading plan that Ms. Ames initially adopted on June 13, 2025, and subsequently modified on September 12, 2025. Following the completion of this specific sale, Ms. Ames's direct holdings in D-Wave Quantum common stock amount to 596,803 shares. This total figure includes a component of 543,750 unvested restricted stock units.


Financial and Strategic Developments for D-Wave Quantum Inc.

Beyond the insider transaction, D-Wave Quantum Inc. issued its financial results for the first quarter of 2026 (Q1 2026). The company reported an earnings per share (EPS) figure of -$0.05. This result was notable because it exceeded the consensus estimates provided by analysts, who had anticipated an EPS of -$0.08.

However, the revenue figures presented a mixed picture. While the EPS performance showed strength relative to expectations, the reported revenue for the quarter reached $2.9 million. This figure represented a shortfall when compared to the projected revenue of $4.14 million.

Adding to the company's recent announcements was securing a Letter of Intent (LOI) for substantial future funding. D-Wave Quantum announced that it has entered into an agreement proposing $100 million in financial backing through the U.S. CHIPS and Science Act. The designated purpose of this major funding injection is to facilitate the advancement and scaling of D-Wave’s quantum computing systems. These efforts will be concentrated at the company's established research and development facilities located across multiple regions: Florida, Connecticut, and British Columbia.


Market Analysis and Valuation Context

From a broader analytical perspective, information from InvestingPro suggests that QBTS may currently appear overvalued when compared to its calculated Fair Value assessment. The platform provides comprehensive resources, including a list of most overvalued stocks and detailed Pro Research Reports, which are intended to offer deeper insights into the company's valuation metrics and overall financial health.


Key Takeaways from Recent Activity